Dr. Maria Azmanova,Lecturer in Medicinal Chemistry
Information about Dr. Maria Azmanova at the University of Bradford.
- School of Pharmacy & Medical Sciences
(Faculty of Life Sciences) - Email:
- m.azmanova1@bradford.ac.uk
- Telephone:
- +44 1274 238668
Biography
Dr Maria Azmanova holds an MChem (University of Bradford, 2018) and a PhD in Medicinal Chemistry (University of Bradford, 2022). Maria is appointed as a Lecturer in Medicinal Chemistry in the School of Pharmacy and Medical Sciences, University of Bradford. Maria is a Fellow of the Higher Education Academy, UK (2024) and Member of the Royal Society of Chemistry (MRSC). She has experience in leading, developing and accreditation of innovative programmes of study in life sciences at an undergraduate level, including MPharm (GPhC). Maria has experience in the field of student progression and attainment, with a focus on life sciences and international students. Her research interests and expertise range from laboratory-based research such as inorganic chemistry, organometallic chemistry, metallodrugs with anticancer/antibacterial properties, oxidative stress in cancer therapy, as well as educational research around learner analytics and early indicators of student engagement.
Publications
There are 8 publications involving or that are attributed to Dr. Maria Azmanova.
Peer Reviewed Journal
Title | Year | Publication name | Journal | Volume | Pages | Authors | Editors | ISSN | Publisher | DOI | Location |
---|---|---|---|---|---|---|---|---|---|---|---|
Schizophrenia: synthetic strategies and recent advances in drug design | 2018 | Azmanova, Maria; Pitto-Barry, Anaïs; Barry, Nicolas P.E. | |||||||||
Evaluation of the Toxicity of Two Electron-Deficient Half-Sandwich Complexes against Human Lymphocytes from Healthy Individuals. | 2021 | ChemMedChem | 16 | Habas K;Soldevila-Barreda JJ;Azmanova M;Rafols L;Pitto-Barry A;Anderson D;Barry NPE; | 1860-7187 | 10.1002/cmdc.202000672 | |||||
Oxidative Stress in Cancer Therapy: Friend or Enemy? | 2022 | ChemBioChem | 23 | Azmanova M;Pitto-Barry A; | 1439-7633 | 10.1002/cbic.202100641 | |||||
Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria. | 2022 | Current Research In Microbial Sciences | 3 | Nolan VC;Rafols L;Harrison J;Soldevila-Barreda JJ;Crosatti M;Garton NJ;Wegrzyn M;Timms DL;Seaton CC;Sendron H;Azmanova M;Barry NPE;Pitto-Barry A;Cox JAG; | 2666-5174 | 10.1016/j.crmicr.2021.100099 | |||||
Anticancer water-soluble organoruthenium complexes: synthesis and preclinical evaluation. | 2022 | ChemBioChem | e202200259 | Pitto-Barry A;Azmanova M;Rafols L;Cooper PA;Seaton CC;Shnyder SD; | 1439-7633 | 10.1002/cbic.202200259 | |||||
Synthesis, characterisation, and in vitro anticancer activity of catalytically active indole-based half-sandwich complexes | 2020 | Molecules | I don't know | Joan J. Soldevila-Barreda, Kehinde B. Fawibe, Maria Azmanova, Laia Rafols, Anaïs Pitto-Barry, Uche B. Eke and Nicolas P. E. Barry | |||||||
Preclinical Anticancer Activity of an Electron-Deficient Organoruthenium(II) Complex | 2020 | ChemMedChem | Soldevila-Barreda J.J.;Azmanova M.;Pitto-Barry A.;Cooper P.A.;Shnyder S.D.;Barry N.P.E. | 1860-7179 | 10.1002/cmdc.202000096 | ||||||
Anticancer activity of electron-deficient metal complexes against colorectal cancer in vitro models | 2019 | ChemMedChem | 14 | Maria Azmanova, Joan Soldevila-Barreda, Hira Bani Hani, Rianne M. Lord, Anaïs Pitto-Barry, Steven M. Picksley, Nicolas P. E. Barry | http://dx.doi.org/10.1002/cmdc.201900528 |